Merck & Co Inc (MRK)
127.57
+0.06
(+0.05%)
USD |
NYSE |
May 06, 16:00
127.27
-0.30
(-0.24%)
Pre-Market: 08:46
Merck Gross Profit (Quarterly): 12.24B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.24B |
December 31, 2023 | 10.72B |
September 30, 2023 | 11.70B |
June 30, 2023 | 11.01B |
March 31, 2023 | 10.56B |
December 31, 2022 | 9.949B |
September 30, 2022 | 11.02B |
June 30, 2022 | 10.38B |
March 31, 2022 | 10.52B |
December 31, 2021 | 9.647B |
September 30, 2021 | 9.704B |
June 30, 2021 | 8.298B |
March 31, 2021 | 7.428B |
December 31, 2020 | 5.919B |
September 30, 2020 | 7.916B |
June 30, 2020 | 6.606B |
March 31, 2020 | 8.745B |
December 31, 2019 | 2.576B |
September 30, 2019 | 8.407B |
June 30, 2019 | 8.359B |
March 31, 2019 | 7.764B |
December 31, 2018 | 7.709B |
September 30, 2018 | 7.175B |
June 30, 2018 | 7.048B |
March 31, 2018 | 6.853B |
Date | Value |
---|---|
December 31, 2017 | 6.993B |
September 30, 2017 | 7.018B |
June 30, 2017 | 6.814B |
March 31, 2017 | 6.385B |
December 31, 2016 | 6.644B |
September 30, 2016 | 7.127B |
June 30, 2016 | 6.266B |
March 31, 2016 | 5.74B |
December 31, 2015 | 6.365B |
September 30, 2015 | 6.312B |
June 30, 2015 | 6.031B |
March 31, 2015 | 5.856B |
December 31, 2014 | 6.733B |
September 30, 2014 | 6.334B |
June 30, 2014 | 6.041B |
March 31, 2014 | 6.361B |
December 31, 2013 | 6.713B |
September 30, 2013 | 6.928B |
June 30, 2013 | 6.726B |
March 31, 2013 | 6.712B |
December 31, 2012 | 7.577B |
September 30, 2012 | 7.351B |
June 30, 2012 | 8.199B |
March 31, 2012 | 7.694B |
December 31, 2011 | 8.118B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
2.576B
Minimum
Dec 2019
12.24B
Maximum
Mar 2024
9.085B
Average
9.676B
Median
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 4.247B |
Johnson & Johnson | 14.87B |
Eli Lilly and Co | 7.094B |
Pfizer Inc | 11.50B |
Moderna Inc | 71.00M |